Haldol

Haldol is a prescription medication whose active ingredient is haloperidol. It is supplied as an intramuscular preparation and is marketed in the European Union. As a butyrophenone antipsychotic, Haldol works by blocking dopamine D2 receptors, which helps manage certain psychiatric conditions. The product is classified as a prescription‑only drug and is used under medical supervision.

Haldol is indicated for several psychiatric disorders where rapid symptom control is needed. It is commonly prescribed in acute care settings and may be used as part of a broader treatment plan. - Management of schizophrenia, particularly during acute exacerbations. - Treatment of acute psychosis associated with mood disorders. - Control of manic episodes in bipolar disorder. - Reduction of severe tics in Tourette syndrome. - Adjunctive therapy for agitation in patients with delirium.

Haloperidol can cause a range of side effects that vary in frequency and severity. Common: - Drowsiness or sedation, especially after injection. - Extrapyramidal symptoms such as tremor, rigidity, or akathisia. - Dry mouth and increased salivation. - Constipation or gastrointestinal discomfort. - Blurred vision or difficulty focusing. Serious: - Neuroleptic malignant syndrome, a rare but life‑threatening reaction. - Tardive dyskinesia, characterized by involuntary movements. - Significant cardiac arrhythmias, including QT prolongation. - Severe hypotension or orthostatic dizziness. - Hyperprolactinemia leading to hormonal disturbances.

Before initiating Haldol, clinicians should evaluate patient history and monitor for potential risks. - Assess for cardiovascular disease, as haloperidol may affect heart rhythm. - Review any history of movement disorders or extrapyramidal symptoms. - Use caution in patients with liver or kidney impairment. - Monitor for signs of neuroleptic malignant syndrome during treatment. - Evaluate pregnancy and breastfeeding status, as safety data are limited. - Adjust dosage in elderly patients to reduce fall risk.

Haloperidol may interact with other medications, influencing its efficacy and safety profile. Avoid: - Concurrent use with other dopamine antagonists, which can increase extrapyramidal effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole) that raise haloperidol plasma levels. - Medications that prolong the QT interval, such as certain antiarrhythmics. Use with caution: - Other antipsychotics or mood stabilizers, requiring close monitoring. - CNS depressants, including benzodiazepines and opioids, which may enhance sedation. - Anticholinergic agents that could mask early signs of extrapyramidal symptoms.